Traws Pharma, Inc. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q2 2012 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Traws Pharma, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q2 2012 to Q3 2024.
- Traws Pharma, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2024 was -$8.48M, a 78.8% decline year-over-year.
- Traws Pharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2019 was -$21.5M, a 4.47% decline from 2018.
- Traws Pharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2018 was -$20.6M, a 14.4% increase from 2017.
- Traws Pharma, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2017 was -$24.1M, a 22.3% decline from 2016.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)